ARTICLE
17 December 2020

OFAC Clarifies Scope Of Iranian Sanctions

HL
Hogan Lovells Cadwalader

Contributor

Hogan Lovells Cadwalader is a global law firm trusted by clients to deliver on complex, high-stakes matters.

Operating at the intersection of business, finance, and government, we bring an unwavering commitment to client service and the decisive counsel that helps clients achieve exceptional results.

Consistently recognized for innovation across legal services, we combine sharp judgment with deep commercial perspective and intellectual rigor to address critical, cutting-edge challenges.

With 3,100 lawyers worldwide, we offer global scale with strong local insight in the markets that matter most. Our commitment extends beyond client work through pro bono activities, community investment, and responsible business practices.

OFAC revised guidance on sanctions against the Iranian financial sector.
Worldwide International Law
Hogan Lovells Cadwalader are most popular:
  • within International Law, Intellectual Property, Food, Drugs, Healthcare and Life Sciences topic(s)

OFAC revised guidance on sanctions against the Iranian financial sector.

In two new FAQs, OFAC explained that:

  • the prohibitions under Executive Order 13902 ("EO"), including provisions creating potential exposure to secondary sanctions, generally do not apply to transactions related to the conduct of official business of the United Nations, its agencies and certain other international organizations (FAQ 855); and
  • transactions related to certain legal proceedings, including the defense of individuals in legal actions brought by the Government of Iran, may be authorized under the Iran Transactions and Sanctions Regulations, provided that such transactions do not involve persons designated to OFAC's Specially Designated Nationals and Blocked Persons List (or "SDN List") in connection with Iran's support for international terrorism and pursuit of weapons of mass destruction (FAQ 856).

OFAC updated four FAQs clarifying:

  • that OFAC will not target Iranian manufacturers of medicine and medical devices for sanctions, and noting that U.S. law authorizes the export of humanitarian goods, including medicine and medical devices, to Iran (FAQ 830);
  • OFAC's definition, for purposes of EO 13902, of the "mining," "manufacturing," "textiles" and "financial services" sectors of the Iranian economy (FAQ 831);
  • OFAC's interpretation of the term "significant goods and services" in connection with the threat of secondary sanctions under EO 13902 related to dealings with the aforementioned sectors of the Iranian economy (FAQ 832); and
  • that transactions by non-U.S. persons involving the Iranian financial sector generally are not sanctionable under EO 13902 if they would be permissible if conducted by U.S. persons (FAQ 847).

Primary Sources

1.OFAC FAQ: Iran Sanctions - 855

2.OFAC FAQ: Iran Sanctions - 856

3.OFAC FAQ: Iran Sanctions - 830

4.OFAC FAQ: Iran Sanctions - 831

5.OFAC FAQ: Iran Sanctions - 832

6.OFAC FAQ: Iran Sanctions - 847

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More